JPM released a research report stating that CHINA LIFE (02628.HK) +1.220 (+4.453%) Short selling $705.55M; Ratio 24.009% 's 1Q results are likely to trigger market divergence. The bank maintains a positive view, believing that strong new life insurance policy sales form a compelling equity story, largely offsetting the significant decline in earnings caused by A-share market volatility. New business value in 1Q surged 75.5% YoY, far exceeding the banks expectation of above 20%. Momentum in both agency and bancassurance channels remained robust, achieving growth despite a high base in 1Q last year, indicating market share gains and deeper distribution channel capabilities.The bank noted that net profit for the period fell 32% YoY to RMB19.5 billion, below its forecast of a 13% decline. It believes this does not pose significant share price risk, as the dividend policy has shifted to a progressive framework that decouples dividends from reported earnings. Market consensus has already factored in a 19% YoY decline in FY26 net profit, with earnings risks partly reflected in valuation. The core solvency adequacy ratio rose 28 ppts QoQ to 157%, a leading level within the industry.Related NewsCICC Forecast on CN Insurers' 1Q26 NP, NBV (Table)JPM reiterated CHINA LIFE as its top pick with an Overweight rating, expecting a positive share price reaction. The TP is HKD40, based on 8x projected 2026 price-to-earnings ratio. (ec/w)(HK stocks quote is delayed for at least 15 mins.Short Selling Data as at 2026-04-30 16:25.)
AASTOCKS Financial News